Literature DB >> 915308

Isolation of soluble immune complexes by affinity chromatography using staphylococcal protein A--Sepharose as substrate.

F Chenais, G Virella, C C Patrick, H H Fudenberg.   

Abstract

This report describes a technique for the general isolation of immune complexes, based on a combination of gel filtration and affinity chromatography. The first step is the preparation of a globulin-enriched fraction by precipitation with ammonium sulfate at 50% saturation, or of an immune-complex-enriched fraction by precipitation with 5% polyethylene glycol 6000. The enriched fraction is then subfractionated by gel filtration in Ultrogel AcA 34. The immune complexes elute close to the void volume in the macroglobulin peak, separated from monomeric IgG molecules. This peak (sometimes subdivided into two fractions) is then submitted to affinity chromatography on a protein A--Sepharose cooumn. Most immune complexes contain IgG molecules and therefore bind to the column. Almost no protein is bound when normal serum is fractionated according to this method, and no immunoglobulins are detectable in the acid-eluted fraction from the protein A--Sepharose column. In two patients with soluble immune complexes in their sera we eluted immunoglobulin-containing fractions from the column; in one, these fractions had high rheumatoid factor titers; and in the second, with a clinical diagnosis of systemic lupus erythematosus, a similar fraction contained RNA.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915308     DOI: 10.1016/0022-1759(77)90169-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  MC29 virus-coded protein occurs as monomers and dimers in transformed cells.

Authors:  J P Bader; D A Ray
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

2.  Immunocytochemical localization of proteins in differentiating tissues of Pisum sativum.

Authors:  N S Cohn; J P Mitchell
Journal:  Histochemistry       Date:  1986

Review 3.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

4.  Detection of specific antigen within circulating immune complexes: validation of the assay and its application to food antigen-antibody complexes formed in healthy and food-allergic subjects.

Authors:  R Paganelli; R J Levinsky; D J Atherton
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

5.  Isolation and characterization of soluble insulin-anti-insulin immune complexes formed in vitro and in vivo in sera from patients with diabetes mellitus.

Authors:  J M Kilpatrick; G Virella
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

6.  Structural assessment of beta-glucuronidase carbohydrate chains by lectin affinity chromatography.

Authors:  B Wójczyk; D Hoja; A Lityńska
Journal:  Glycoconj J       Date:  1993-04       Impact factor: 2.916

7.  Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.

Authors:  P Casali; P H Lambert
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

8.  Isolation of circulating immune complexes by conglutinin and separation of antigen from dissociated complexes by immobilized protein A.

Authors:  R C Gupta; E M Tan
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

9.  Circulating immune complexes of Hodgkin's disease contain an antigen that is present in Hodgkin and Reed-Sternberg cells.

Authors:  G Bepler; Q Y Zhen; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

10.  The role of circulating immune complexes in the pathogenesis of diabetes mellitus.

Authors:  J M Kilpatrick; G Virella
Journal:  Acta Diabetol Lat       Date:  1982 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.